ClinConnect ClinConnect Logo
Search / Trial NCT03774589

Bilioenteric Anastomosis by Magnetic Compressive Technique

Launched by FIRST AFFILIATED HOSPITAL XI'AN JIAOTONG UNIVERSITY · Dec 12, 2018

Trial Information

Current as of August 02, 2025

Unknown status

Keywords

Bilioenteric Anastomosis Magnetic Compressive Technique Morbidity

ClinConnect Summary

The bilioenteric anastomosis is one of the most common and difficult operations in Hepatobiliary Surgery. The traditional manual anastomosis has become one of the main prognosis factors because of the length of suture time, the difficulty of operation, the high incidence of anastomotic leakage and stricture. Magnetic compressive anastomosis can realize the fast anastomosis, reduce the difficulty, and reduce the incidence of anastomotic leakage and stricture. Currently, the majority of studies of magnetic compressive bilioenteric anastomosis are merely confined within clinical case report an...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with age between 18 to 75
  • Patients' gender was not limited
  • Patients who were well-diagnosed and had the indication for bilioenteric anastomosis.
  • Patients whose lifetimes will be longer than 12 months.
  • Patients who are willing to join this clinical trial and informed consent form voluntarily.
  • Exclusion Criteria:
  • Woman during pregnancy or lactation or anyone with mental disorder
  • The wall of hepatic duct or jejunum was too thick so that the attractive force of magnetic device cannot meet the requirements of compression.
  • Any anatomical variation in bile ducts system or the inner diameter is too small so that the magnetic device cannot place in.
  • Any foreign body has been implanted in body, such as heart pacemaker.
  • * Surgical contraindication, including:
  • Child-Pugh C with hepatic encephalopathy Anyone with heart, lung, kidney dysfunction or other organ dysfunction, and cannot tolerate surgery.Hepatic ducts stone disease, who was diagnosed as Acute Cholangitis of Severe Type, especially complicated with bacteremia or septic shock. End stage disease, complicated with biliary cirrhosis or portal hypertension.Patients with long- term obstructive jaundice, dehydration, electrolyte disturbance or coagulation defects; Patients have the tendency or history of bleeding.
  • • Any other disease in perioperation periods which needs MRI examination in the next 8 weeks post operation.

About First Affiliated Hospital Xi'an Jiaotong University

The First Affiliated Hospital of Xi'an Jiaotong University is a leading medical institution renowned for its commitment to advancing healthcare through clinical research and innovative treatment approaches. As a prominent academic hospital in China, it integrates clinical practice, education, and research, fostering a collaborative environment that enables the development of cutting-edge therapies and medical technologies. With a multidisciplinary team of experts and state-of-the-art facilities, the hospital plays a pivotal role in conducting high-quality clinical trials that aim to improve patient outcomes and contribute to the global medical community.

Locations

Xi'an, Shaanxi, China

Patients applied

0 patients applied

Trial Officials

Yi Lv, MD,PHD

Principal Investigator

China, Shaanxi First Affiliated Hospital of Xian JiaotongUniversity

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials